Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease

BACKGROUND: Class 1C antiarrhythmic drugs (AADs) are effective first‐line agents for atrial fibrillation (AF) treatment. However, these agents commonly are avoided in patients with known coronary artery disease (CAD), due to known increased risk in the postmyocardial infarction population. Whether 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantlin, Peter G., Bober, Robert M., Bernard, Michael L., Khatib, Sammy, Polin, Glenn M., Rogers, Paul A., Morin, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079139/
https://www.ncbi.nlm.nih.gov/pubmed/31912933
http://dx.doi.org/10.1111/jce.14335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079139/
https://www.ncbi.nlm.nih.gov/pubmed/31912933
http://dx.doi.org/10.1111/jce.14335

Ejemplares similares